Not specified · Malta Lifestyle
Benefit-Risk Appraisal Of Medicines: A Systematic Approach To Decision-Making
€109.20
Out of stock
Prices last checked 5 Nov 2026, 05:10 UTC. Delivery and checkout conditions apply.
Single retailer.
Visit retailerCompare retailer offers
Merlin Library
Out of stock · Checked 5 Nov 2026, 05:10 UTC
About this product
Establishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. Outlines how the new MCDA model was developed and evaluated, and discusses the implications of its implementation into the practice of drug evaluation.